Active, not recruitingPhase 2NCT02389244

A Phase II Study Evaluating Efficacy and Safety of Regorafenib in Patients With Metastatic Bone Sarcomas

Studying Bone sarcoma

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
UNICANCER
Principal Investigator
Florence DUFFAUD, MD PhD
La Timone University Hospital
Intervention
Regorafenib(drug)
Enrollment
163 enrolled
Eligibility
10 years · All sexes
Timeline
20142026

Study locations (19)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT02389244 on ClinicalTrials.gov

Other trials for Bone sarcoma

Additional recruiting or active studies for the same condition.

See all trials for Bone sarcoma

← Back to all trials